Opuholi Golovy i Sei最新文献

筛选
英文 中文
A lesion of contralateral neck lymph nodes in oral tongue cancer with clinically negative neck lymph nodes (clinical case) 口腔舌癌伴临床阴性对侧颈部淋巴结病变1例(附1例)
Opuholi Golovy i Sei Pub Date : 2019-10-31 DOI: 10.17650/2222-1468-2019-9-3-83-88
Z. Radzhabova, M. Kotov, S. Novikov, P. I. Krzhivizchki, O. Ponomareva, E. Kostromina, V. Kushnarev, A. Artemieva, M. A. Radzhabova
{"title":"A lesion of contralateral neck lymph nodes in oral tongue cancer with clinically negative neck lymph nodes (clinical case)","authors":"Z. Radzhabova, M. Kotov, S. Novikov, P. I. Krzhivizchki, O. Ponomareva, E. Kostromina, V. Kushnarev, A. Artemieva, M. A. Radzhabova","doi":"10.17650/2222-1468-2019-9-3-83-88","DOIUrl":"https://doi.org/10.17650/2222-1468-2019-9-3-83-88","url":null,"abstract":"The objectiveis to present a clinical case of combined treatment of cancer of the tongue and its progression to the contralateral lymph nodes of the neck using data on individual lymphatic outflow from the primary tumor of the tongue.Clinical case.Clinical, laboratory, radiological and pathomorphological data of a 50-year-old patient with a diagnosis of squamous human papillomavirus-negative cancer of the free part of the tongue and clinically negative lymph nodes of the neck with cT2N0M0. The patient underwent radical surgical treatment in the amount of hemiglossectomy and ipsilateral selective cervical lymphadenectomy after two courses of polychemotherapy according to the cisplatin + 5-fluorocracil regimen with partial regression and adjuvant treatment in the amount of conformal remote radiation therapy combined with chemotherapy. 9 months after the end of treatment, progression to the lymph nodes of the neck of the contralateral side was revealed, which accumulated a radiopharmaceutical before treatment.Conclusion.The described clinical case shows the importance of studying the lymphatic outflow from the primary tumor of the tongue to the regional lymph nodes in order to plan surgical treatment on the regional lymphatic collector in patients with squamous cell carcinoma of the free part of the tongue.","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67780720","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Diagnosed laryngeal cancer relapse using harpoon biopsy under ultrasound guidance (clinical case) 超声引导下鱼叉活检诊断喉癌复发(临床一例)
Opuholi Golovy i Sei Pub Date : 2019-10-31 DOI: 10.17650/2222-1468-2019-9-3-97-101
А. I. Gafurova, V. Vinogradov, А. S. Korobkin, S. S. Reshulsky
{"title":"Diagnosed laryngeal cancer relapse using harpoon biopsy under ultrasound guidance (clinical case)","authors":"А. I. Gafurova, V. Vinogradov, А. S. Korobkin, S. S. Reshulsky","doi":"10.17650/2222-1468-2019-9-3-97-101","DOIUrl":"https://doi.org/10.17650/2222-1468-2019-9-3-97-101","url":null,"abstract":"The objective is to demonstrate possibilities of a harpoon biopsy under ultrasound guidance for malignant neoplasms early detection using a clinical example.Clinical case. A 65-year-old patient with morphologically verified laryngeal cancer (stage II, T2N0M0) underwent radiation therapy, which resulted in a complete tumor resorption. Subsequent ultrasound detected a neoplasm in the projection of the folding section. Percutaneous harpoon biopsy was performed under ultrasound guidance because standard clinical and instrumental studies were unable to confirm the diagnosis. Histological study of the biopsy material confirmed the “relapse of larynx squamous cell carcinoma”.Conclusion. A transdermal harpoon biopsy under ultrasound guidance followed by morphological biopsy study makes it possible to diagnose the disease and determine therapeutic approach as soon as possible.","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67780983","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in squamous cell carcinoma of the head and neck (literature review) 18f -氟脱氧葡萄糖正电子发射断层扫描联合计算机断层扫描在头颈部鳞状细胞癌中的应用(文献复习)
Opuholi Golovy i Sei Pub Date : 2019-10-31 DOI: 10.17650/2222-1468-2019-9-3-49-60
О. D. Ryzhova, М. B. Dolgushin, A. Mikhaylov, Е. L. Dronova, D. I. Nevzorov, А. M. Mudunov, S. Alieva
{"title":"18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in squamous cell carcinoma of the head and neck (literature review)","authors":"О. D. Ryzhova, М. B. Dolgushin, A. Mikhaylov, Е. L. Dronova, D. I. Nevzorov, А. M. Mudunov, S. Alieva","doi":"10.17650/2222-1468-2019-9-3-49-60","DOIUrl":"https://doi.org/10.17650/2222-1468-2019-9-3-49-60","url":null,"abstract":"Most of the malignant neoplasms of the head and neck are represented by squamous cell carcinoma. 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in squamous cell carcinoma of the head and neck is applied for primary staging, treatment planning, treatment response assessment evaluation and progression detection. The article presents a literature review on the use of 18F-fluorodeoxyglucose positron emission tomography combined with computed tomography in head and neck squamous cell carcinoma patients, and major trends of other radiopharmaceuticals usage in this nosology.","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67779831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound diagnosis of oropharyngeal squamous cell carcinoma and ultrasound evaluation of treatment efficacy (changes in tumor volume) 口咽鳞状细胞癌的超声诊断及疗效评价(肿瘤体积变化)
Opuholi Golovy i Sei Pub Date : 2019-10-31 DOI: 10.17650/2222-1468-2019-9-3-12-23
G. Allakhverdieva, G. Т. Sinyukova, V. Sholokhov, Т. Y. Danzanova, О. A. Saprina, Е. А. Gudilina
{"title":"Ultrasound diagnosis of oropharyngeal squamous cell carcinoma and ultrasound evaluation of treatment efficacy (changes in tumor volume)","authors":"G. Allakhverdieva, G. Т. Sinyukova, V. Sholokhov, Т. Y. Danzanova, О. A. Saprina, Е. А. Gudilina","doi":"10.17650/2222-1468-2019-9-3-12-23","DOIUrl":"https://doi.org/10.17650/2222-1468-2019-9-3-12-23","url":null,"abstract":"The study objectiveis to assess the capabilities of ultrasonography in the diagnosis of oropharyngeal squamous cell carcinomas and in the evaluation of treatment efficacy (changes in tumor volume).Materials and methods.This study included 98 patients (27 (27.5 %) females and 71 (72.5 %) males aged between 20 and 78 years with oropharyngeal tumors; of them, 12 (12.2 %) patients had recurrent tumors. Sixty-seven (68.4 %) participants had their tumors located in the tonsils; 31 (31.6 %) patients had tumors of the root of the tongue; 47 (48.0 %) patients presented with tumors invading adjacent tissues; 57 (58.2 %) patients had their lymph nodes involved. Thirty-two patients were operated at the first stage of treatment, whereas 66 (67.3 %) individuals received induction chemotherapy followed by sequential chemoradiotherapy. Treatment efficacy was evaluated 2 weeks following the completion of the second course of induction chemotherapy. We assessed tumor volume, its structure, type and intensity of vascularization, and the number and size of lymph nodes affected by metastasis. Ultrasonography findings were compared with the results of fibroscopy, X-ray computed tomography (CT) and magnetic resonance imaging (MRI) performed 2 weeks following the completion of the second course of induction chemotherapy (no later than 7–10 days).Results.The disagreement between histology and ultrasonography findings reflecting tumor volume (of either newly diagnosed or recurrent tumor) was statistically insignificant. The results of X-ray CT were more likely to be in agreement with histology than the ultrasonography results (85.0 % vs 70.0 %); however, this difference was not statistically significant. Data of X-ray CT and ultrasonography on the tumor volume demonstrated no significant difference between them. MRI and ultrasonography findings on the tumor volume were consistent in 50 % of cases. We identified the most common changes in the structure of the oropharyngeal tumors typical of positive and negative dynamics after 2 courses of induction chemotherapy. Patients with positive dynamics demonstrated a significant decrease in tumor volume detected by all diagnostic methods used (ultrasonography, X-ray CT, and MRI). There was a significant negative correlation between the efficacy of treatment assessed by ultrasonography and the grade of therapeutic pathomorphosis assessed by histology (r = –0.69; р = 0.0014).Conclusion.The accuracy of ultrasonography for the estimation of oropharyngeal tumor volume and its spread is comparable with that of X-ray CT and MRI. The disagreement between these methods was statistically insignificant. Ultrasonography is a more sensitive method for the evaluation of patient response to treatment than clinical data.","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67780022","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Efficacy of vandetanib in the treatment of medullary thyroid cancer: literature review and case report 万德替尼治疗甲状腺髓样癌的疗效:文献复习及病例报告
Opuholi Golovy i Sei Pub Date : 2019-10-31 DOI: 10.17650/2222-1468-2019-9-3-38-48
А. M. Mudunov, Y. Alymov, I. Romanov, S. Podvyaznikov, А. V. Ignatova
{"title":"Efficacy of vandetanib in the treatment of medullary thyroid cancer: literature review and case report","authors":"А. M. Mudunov, Y. Alymov, I. Romanov, S. Podvyaznikov, А. V. Ignatova","doi":"10.17650/2222-1468-2019-9-3-38-48","DOIUrl":"https://doi.org/10.17650/2222-1468-2019-9-3-38-48","url":null,"abstract":"Medullary thyroid cancer (MTC) is a rare disorder that accounts for approximately 1.7 % of all thyroid malignancies. MTC is usually detected at early stages; however, approximately 10–15 % of patients are diagnosed with locally advanced MTC and distant metastases. Treatment of such patients is challenging due to biological characteristics of the disease and very few effective treatment approaches available. The investigation of mechanisms of carcinogenesis, as well as advances in pharmacology, allowed the development of a new group of targeted drugs, namely tyrosine kinases, which efficacy against progressive unresectable locally advanced or metastatic MTC has been demonstrated in multiple clinical trials. Vandetanib has been registered for MTC treatment in the Russian Federation. MTC is very rare, thus, each case of vandetanib use for its treatment is particularly interesting. Moreover, since the approval of this drug in 2011 by the U. S. Food and Drug Administration (FDA), new data on the clinical use of vandetanib have been accumulated. Importantly, clinical trials are usually well designed and conducted in near-ideal conditions, whereas the real conditions can be different and patients may have individual characteristics. Therefore, the aim of this study was to update the information on the efficacy and safety of vandetanib by retrospective analysis of available publications and to report a case of MTC treated with vandetanib.","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"14 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67779816","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Possibilities of single photon emission tomography in the diagnosis of bone metastases in patients with disseminated medullary thyroid carcinoma (case report) 单光子发射断层扫描诊断弥散性甲状腺髓样癌骨转移的可能性(附1例报告)
Opuholi Golovy i Sei Pub Date : 2019-07-02 DOI: 10.17650/2222-1468-2019-9-2-81-87
E. Stanyakina, I. Romanov, A. Krylov, A. Ryzhkov, K. D. Ilkaev, А. B. Bludov, S. Kaspshik
{"title":"Possibilities of single photon emission tomography in the diagnosis of bone metastases in patients with disseminated medullary thyroid carcinoma (case report)","authors":"E. Stanyakina, I. Romanov, A. Krylov, A. Ryzhkov, K. D. Ilkaev, А. B. Bludov, S. Kaspshik","doi":"10.17650/2222-1468-2019-9-2-81-87","DOIUrl":"https://doi.org/10.17650/2222-1468-2019-9-2-81-87","url":null,"abstract":"The study objective : using a clinical example to demonstrate possibilities of single photon emission computerized tomography (SPECT) in combination with computed tomography (CT) in identifying latent bone metastases, taking into account the dynamics growth of serum basal calcitonin. Materials and methods . Patient S., 60 years old, visited N.N. Blokhin National Medical Research Center of Oncology for consultation on multiple lung metastases of cancer of unknown primary. Results. Taking into account basal calcitonin level, immunohistochemistry, ultrasound investigation andfine-needle aspiration biopsy of the node in the right thyroid lobe a diagnose of medullary thyroid cancer was made. CT revealed multiple metastases in both lungs. Specialist erformed thyroidectomy with central lymphadenectomy and facial neck dissection on both sides. During next four months basal calcitonin level increased twice. Control contrast CT lung screening showed the growth of previously identified metastases and the appearance of multiple new ones. Bone scan showed focuses of increased radio-pharmaceutical accumulation in the area of 7 h left rib, left iliac wing, in the left bones of cranial vault, in C 7 , Th 6 , Th 9 , Th I2 vertebrae and right foot bones. Additional examination using SPECT/CT (from the skull base to the hip joints) revealed metastases in corpuses of Th 9 , Th I2 vertebrae and the left iliac wing, and suspicion for metastasis in 7 h left rib. Magnetic resonance imaging (MRI) confirmed metastasis in Th 9 , Th I2 , L 3 vertebral bodies and in the left iliac wing. Conclusion. Conclusion . In this clinical example, SPECT/CT allowed to correctly detect metastases in both Th 9 and Th I2 vertebrae while bone scan was questionable, and MRI showed an additional damage of L 3 vertebra. Changes in the 7 h left rib could not be verified using CT, although this changes may be an emerging metastasis. Obviously, extensive use of radiation methods does not guarantee complete identification of all pathological focuses, it therefore allows assessing the prevalence of the pathological process. It is crucially important to control calcitonin level in these patients, since its rapid growth allowed suspecting additional distant metastases.","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67778982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence, clinical significance and possible correction of taste and smell abnormalities in patients with oncological diseases 肿瘤患者味觉和嗅觉异常的患病率、临床意义及可能的纠正
Opuholi Golovy i Sei Pub Date : 2019-07-02 DOI: 10.17650/2222-1468-2019-9-2-53-65
A. Gevorkov, A. Boyko, E. E. Volkova, S. Shashkov
{"title":"Prevalence, clinical significance and possible correction of taste and smell abnormalities in patients with oncological diseases","authors":"A. Gevorkov, A. Boyko, E. E. Volkova, S. Shashkov","doi":"10.17650/2222-1468-2019-9-2-53-65","DOIUrl":"https://doi.org/10.17650/2222-1468-2019-9-2-53-65","url":null,"abstract":"А. Р. Геворков, А. В. Бойко, Е. Э. Волкова, С. В. Шашков Московский научно-исследовательский онкологический институт им. П. А. Герцена – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии» Минздрава России; Россия, 125284 Москва, 2-й Боткинский пр., 3; ООО «Нутриция Эдванс», Россия, 143421 Московская область, Красногорский район, автодорога «Балтия», 26-й км, БЦ «Рига Лэнд», блок В","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"35 4 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67777887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
HPV-negative oropharyngeal carcinoma as a separate prognostkally unfavorable form of cancer, requiring new approaches to treatment (case report) hpv阴性口咽癌作为一种单独的预后不利的癌症形式,需要新的治疗方法(病例报告)
Opuholi Golovy i Sei Pub Date : 2019-07-02 DOI: 10.17650/2222-1468-2019-9-2-71-80
A. Gevorkov, A. Boyko, A. Polyakov, L. Bolotina, N. Volchenko, I. V. Rebrikova, A. Lemeshko, S. Shashkov
{"title":"HPV-negative oropharyngeal carcinoma as a separate prognostkally unfavorable form of cancer, requiring new approaches to treatment (case report)","authors":"A. Gevorkov, A. Boyko, A. Polyakov, L. Bolotina, N. Volchenko, I. V. Rebrikova, A. Lemeshko, S. Shashkov","doi":"10.17650/2222-1468-2019-9-2-71-80","DOIUrl":"https://doi.org/10.17650/2222-1468-2019-9-2-71-80","url":null,"abstract":"The study objective is to demonstrate the difficulties associated with treatment of HPV-negative oropharyngeal cancer. Material and methods . A 52-year-old male patient visited a doctor in P.A. Herzen Moscow Oncology Research Institute in January 2017 with complaints of pain in the right part of the oropharynx irradiating to the right ear and difficulties with swallowing food and liquids. The patient was diagnosed with stage IVA oropharyngeal cancer (cT3N2bM0). Results. The patient underwent a course chemoradiotherapy (CRT); as a result, the tumor in the area of the right tonsil became indeterminable 2 weeks later. Three months after completing the course of CRT, the patient underwent modified radical right-sided lymph node dissection. Histological examination revealed metastases from poorly differentiated squamous cell carcinoma in 3 lymph nodes (LNs) with an invasion into adjacent adipose tissue. In October 2017, we received a histological confirmation of ongoing tumor growth in the area of the tongue root and LN metastases in the left side of the neck (yrpT4aN2cM0). We performed resection of the mandible, tongue, soft tissues of the oral floor, and right side of the oropharynx with installation of an oropharyngeal stoma, extended radical left-sided neck lym-phadenectomy with excision of soft tissues (levels I—V), defect repair using an autologous pectoral musculocutaneous flap, and tracheostomy. In March 2018, the patient was found to have continuing tumor growth in the area of the epiglottis and floor of the oral cavity. The patient underwent laryngectomy with oropharyngeal resection and end tracheostomy. In July 2018, we again received a histological confirmation of tumor growth in soft tissues of the anterior neck. We performed resection of the tumor and soft tissues with subsequent plastic reconstruction of the defect. In October 2018, the patient presented with multiple metastases in both lungs. He received a course of immune therapy. Positron emission tomography revealed neoplastic foci with pathological metabolic activity in the area of the alveolar process of the mandible (left side), soft tissues of the neck, lungs, left-sided axillary LNs, and mediastinal LNs. It was decided to continue immune therapy. Conclusion. HPV-negative oropharyngeal cancer requires an optimized treatment algorithm and, possibly, more aggressive therapeutic measures, such as increased radiation doses. Both overall management strategy and recommended standard scheme of CRT should be revised; the role of surgical and chemotherapeutic components of treatment should also be reassessed. We believe that surgical intervention should be considered regardless of the effect of radiation therapy, while the duration of follow-up after CRT should be reduced.","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67777937","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Removal of a maxillary tumor with simultaneous placement of intraosseous zygomatic implants 切除上颌肿瘤并同时植入骨内颧骨植入物
Opuholi Golovy i Sei Pub Date : 2019-07-02 DOI: 10.17650/2222-1468-2019-9-2-88-94
S. Epifanov, A. Polyakov, A. V. Mordovskiy, D. V. Dorokhin, O. V. Matorin, I. V. Rebrikova, N. V. Vereshchagina
{"title":"Removal of a maxillary tumor with simultaneous placement of intraosseous zygomatic implants","authors":"S. Epifanov, A. Polyakov, A. V. Mordovskiy, D. V. Dorokhin, O. V. Matorin, I. V. Rebrikova, N. V. Vereshchagina","doi":"10.17650/2222-1468-2019-9-2-88-94","DOIUrl":"https://doi.org/10.17650/2222-1468-2019-9-2-88-94","url":null,"abstract":"С. А. Епифанов , А. П. Поляков, А. В. Мордовский, Д. В. Дорохин, О. В. Маторин, И. В. Ребрикова, Н. В. Верещагина Московский научно-исследовательский онкологический институт им. П. А. Герцена – филиал ФГБУ «Национальный медицинский исследовательский центр радиологии Минздрава России»; Россия, 125284 Москва, 2-й Боткинский пр., 3; ФГБУ «Национальный медико-хирургический центр им. Н. И. Пирогова» Минздрава России; Россия, 105203 Москва, ул. Нижняя Первомайская, 70","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2019-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"67779040","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Хирургическое лечение рака гортаноглотки: обзор литературы 喉癌外科治疗:文学评论
Opuholi Golovy i Sei Pub Date : 2019-07-01 DOI: 10.17650/2222-1468-2019-9-2-35-42
З. А.-Г. Раджабова, М. А. Котов, Александр Сергеевич Митрофанов, М. А. Раджабова, Е. В. Левченко
{"title":"Хирургическое лечение рака гортаноглотки: обзор литературы","authors":"З. А.-Г. Раджабова, М. А. Котов, Александр Сергеевич Митрофанов, М. А. Раджабова, Е. В. Левченко","doi":"10.17650/2222-1468-2019-9-2-35-42","DOIUrl":"https://doi.org/10.17650/2222-1468-2019-9-2-35-42","url":null,"abstract":"Surgical resection is one of the standard treatment options for cancer of the larynx, regardless of whether it is combined with postoperative radiotherapy. Reconstruction of the postoperative defect often requires after removal of the tumor. The type of surgery and the reconstructive strategy (selecting recovery methods) depend on the extent of the lesion and the number of departments involved. This article presents a review of the literature on the treatment of cancer of the larynx and the choice of optimal surgical tactics.","PeriodicalId":36598,"journal":{"name":"Opuholi Golovy i Sei","volume":"9 1","pages":"35-42"},"PeriodicalIF":0.0,"publicationDate":"2019-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47151394","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信